{"id":3105,"date":"2015-11-20T07:30:00","date_gmt":"2015-11-20T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/steen-solution-approved-in-china\/"},"modified":"2015-11-20T07:30:00","modified_gmt":"2015-11-20T07:30:00","slug":"steen-solution-approved-in-china","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/","title":{"rendered":"STEEN Solution\u2122 approved in China"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>XVIVO Perfusion has received approval of STEEN Solution\u2122 by the China Food and Drug Administration (CFDA). This enables the company to market and sell STEEN Solution\u2122 for clinical use in China.<\/strong><\/div>\n<\/p>\n<p><span>CFDA has approved STEEN Solution \u2122 for lung transplantation, which allows sales of STEEN Solution \u2122 for clinical use in lung transplants in China. China currently accounts for less than five percent of all lung transplants in the world, despite the large share of the world\u2019s population, but the market has shown rapid growth in recent years and there is a great need for more donated lungs for lung transplantation.<\/span><\/p>\n<\/p>\n<p><span>&#34;The approval of STEEN Solution \u2122 in China is important for future growth because there is a great need for lung transplants and an interest in utilizing EVLP with STEEN Solution \u2122 to increase the availability of usable donor lungs. To be present early in the growth phase and establish the products increases the chances of becoming a leader when the market matures,&#34; says Magnus Nilsson, CEO of XVIVO Perfusion.<\/span><\/p>\n<\/p>\n<p><span>November 20, 2015<br \/><\/span><span>Gothenburg<br \/><\/span><span>XVIVO Perfusion AB (publ)<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span>For further information please contact:<br \/><\/span><br \/><span>Christoffer Rosenblad, CFO, 1 720 616 2101, <a href=\"mailto:christoffer.rosenblad@xvivoperfusion.com\" rel=\"nofollow\">christoffer.rosenblad@xvivoperfusion.com<\/a><\/span><br \/><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, <a href=\"http:\/\/www.xvivoperfusion.com\" rel=\"nofollow\">www.xvivoperfusion.com<\/a><\/span><\/p>\n<p><span>The information was submitted for publication on\u00a0November 20, 2015\u00a0at 8:30 a.m.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO Perfusion has received approval of STEEN Solution\u2122 by the China Food and Drug Administration (CFDA). This enables the company&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3105","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>STEEN Solution\u2122 approved in China - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STEEN Solution\u2122 approved in China - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion has received approval of STEEN Solution\u2122 by the China Food and Drug Administration (CFDA). This enables the company...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-approved-in-china\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-approved-in-china\\\/\",\"name\":\"STEEN Solution\u2122 approved in China - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2015-11-20T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-approved-in-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-approved-in-china\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-approved-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STEEN Solution\u2122 approved in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STEEN Solution\u2122 approved in China - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/","og_locale":"en_US","og_type":"article","og_title":"STEEN Solution\u2122 approved in China - XVIVO","og_description":"XVIVO Perfusion has received approval of STEEN Solution\u2122 by the China Food and Drug Administration (CFDA). This enables the company...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/","name":"STEEN Solution\u2122 approved in China - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2015-11-20T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-approved-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"STEEN Solution\u2122 approved in China"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}